Skip to main navigation
Skip to content
Cincor Logo
Menu
  • Home
  • About
  • Baxdrostat (CIN-107)
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events and Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Corporate Governance
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
    • IR Resources
      • Overview
      • Email Alerts
      • Contact IR
  • Contact

INVESTORS >> News Releases

News Release
June 1, 2022
CinCor Pharma Doses First Patient in Phase 2 FigHTN-CKD Trial Evaluating the Selective Aldosterone Synthase Inhibitor Baxdrostat (CIN-107) in Patients with Uncontrolled Hypertension and Chronic Kidney Disease
News Release
May 31, 2022
CinCor Pharma to Present at the Jefferies Healthcare Conference
News Release
May 17, 2022
CinCor Pharma to Present at Upcoming Investor Conferences
News Release
May 10, 2022
CinCor Reports First Quarter Financial Results and Provides Corporate Update
News Release
April 19, 2022
CinCor Pharma to Participate in Jefferies Biotech on the Bay Summit
News Release
March 22, 2022
CinCor Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
News Release
March 17, 2022
CinCor Pharma to be Added to Russell 2000® and Russell 3000® Indexes
News Release
March 15, 2022
CinCor Pharma to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on March 22, 2022
News Release
March 3, 2022
CinCor Pharma to Present at the 32nd Annual Oppenheimer Healthcare Conference
News Release
January 13, 2022
CinCor Pharma Appoints June Lee to Its Board of Directors

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 12
  • Email Alerts
  • Contact Us
  • RSS Feeds
  • Home
  • About
  • Baxdrostat (CIN-107)
  • Pipeline
  • Investors
  • Contact
Cincor Logo
© 2022 CinCor. All rights reserved
  • Privacy
  • LinkedIn
  • Twitter